z-logo
Premium
Copper (II) ions potently inhibit purified PrPres amplification
Author(s) -
Orem Nicholas R.,
Geoghegan James C.,
Deleault Nathan R.,
Kascsak Richard,
Supattapone Surachai
Publication year - 2006
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2006.03650.x
Subject(s) - in vitro , in vivo , chemistry , pathogenesis , scrapie , hamster , gene isoform , microbiology and biotechnology , chelation , molecule , peptide , biochemistry , biology , prion protein , inorganic chemistry , immunology , medicine , disease , organic chemistry , pathology , gene
The structural conversion of a host protein, PrP C , into a protease‐resistant isoform, PrPres, is the central event in the pathogenesis of infectious prion diseases. Purification of native PrP C molecules from hamster brain by either cation exchange or immobilized chelator chromatographic resins yielded preparations that supported efficient amplification of scrapie‐induced PrPres in vitro . Using these purified preparations, we determined that in vitro PrPres amplification was inhibited by CuCl 2 and ZnCl 2 at IC 50 concentrations of ∼400 n m and 10 μ m , respectively. In contrast, 100 μ m MnCl 2 did not directly inhibit PrPres amplification or block Cu 2+ ‐mediated inhibition. Additionally, the inhibition of PrPres amplification by Cu 2+ ions could be reversed by addition of either neocuproine or imidazole. Cu 2+ inhibited PrPres amplification in both the presence and absence of stimulatory polyanion molecules. These biochemical findings support the hypothesis that Cu 2+ ions might regulate the pathogenesis of prion diseases in vivo .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom